EGF Theramed Health Corp.
EVAHF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $3 | $0 | $0 |
| Gross Profit | $0 | -$3 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $168 | $434 | $867 |
| SG&A Expenses | $202 | $228 | $434 | $971 |
| Sales & Mktg Exp. | $0 | $60 | $0 | $104 |
| Other Operating Expenses | $0 | $66 | $173 | $34 |
| Operating Expenses | $202 | $294 | $606 | $1,005 |
| Operating Income | -$202 | -$297 | -$606 | -$1,005 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$1,559 | $1 | -$37 | -$359 |
| Pre-Tax Income | -$1,761 | -$296 | -$643 | -$1,364 |
| Tax Expense | $611 | $0 | $0 | $0 |
| Net Income | -$2,355 | -$269 | -$623 | -$1,350 |
| % Margin | – | – | – | – |
| EPS | -0.2 | -0.024 | -0.062 | -0.63 |
| % Growth | -733.3% | 61.5% | 90.1% | – |
| EPS Diluted | -0.2 | -0.024 | -0.062 | -0.63 |
| Weighted Avg Shares Out | 11,596 | 11,211 | 9,989 | 2,155 |
| Weighted Avg Shares Out Dil | 11,596 | 11,212 | 9,989 | 2,155 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $1 |
| Interest Expense | $48 | $36 | $38 | $15 |
| Depreciation & Amortization | $0 | $231 | $39 | $1 |
| EBITDA | -$1,713 | $0 | -$567 | -$990 |
| % Margin | – | – | – | – |